65,437 trials
Influenza
Primary: Geometric Mean Titers Against Influenza B Strains After Vaccination With Fluzone® Quadrivalent Influenza Vaccine or With Trivalent Influenza Vaccines With Corresponding…
Pre-diabetes
Primary: Change in High-sensitivity C-reactive Protein — 0.72; -0.61 mg/dl
Gestational Diabetes · Hyperlipidemia
Primary: Cholesterol — 204; 201 mg/dl
Asthma
Primary: Number of Participants With 1 or More Severe Asthma Exacerbations — 186; 154 participants — p=0.036
Asthma
Primary: Weighted Mean Change From Baseline in Forced Expiratory Volume in One Second (FEV1) Between 0-2 Hours, Following the 22-23 Hour Post-treatment Allergen Challenge on Day…
Hernia
Primary: Overall Postsurgical Analgesic Use — 9.7 mg (morphine equivalents)
Quadriplegia · Spinal Cord Injury · ALS
Primary: Fitts' Law: Horizontal Tapping Using TDS, Keypad, and Mouse (Throughput) — 1.97; 2.03; 1.54; 2.04 bits per second
Recurrent Colon Cancer · Recurrent Rectal Cancer · Stage IV Colon Cancer
Primary: Progression-free Survival Rate — 5.3 percentage of participants
Advanced Malignant Mesothelioma · Epithelial Mesothelioma · Localized Malignant Mesothelioma
Primary: Objective Response Rate, Complete (CR) or Partial (PR) Response — 5 percentage of participants
Rhinitis Allergic · Conjunctivitis
Primary: Average Total Combined Rhinoconjunctivitis Daily Symptom Score (DSS) and Rhinoconjunctivitis Daily Medication Score (DMS) Over the Entire Grass Pollen Season (GPS)…
Kidney Diseases · Kidney Failure, Chronic · Kidney Failure
Primary: Plasma Creatine Concentration of the Recipients — 849.5; 878.5; 771.0; 776.5 μmol/l
Breast Cancer
Primary: Time to Invasive Disease-free Survival (IDFS) Event — NA; NA Months — p=0.1810
Surgical Technique
Primary: Intraoperative Duration — 22.5; 12.8 Min
Multiple Sclerosis
Primary: No.of Gd+ Lesions From Week 8 to Week 24 — 46; 33; 5; 13 participants — p=0.04
Asthma Patients
Primary: Pre-bronchodilator FEV1 at the Clinic — 0.16; 0.19; 0.19; 0.15 Liters